Results 151 to 160 of about 171,935 (300)

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival

Brain Pathology, EarlyView.
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira, Yaiza López‐Sampere, Pol Mengod‐Soler, Mario Peña‐Fonteboa, Carla Marco, Alejandro Caravaca‐Puchades, Raúl Domínguez, Juan Francisco Vázquez‐Costa, Enrique Santamaría, Joaquín Fernández‐Irigoyen, María J. Colomina, Isabel León Moreno, Antonio Martínez Yélamos, Sergio Martínez Yélamos, Gabriel Santpere, Elia Obis, Manuel Portero‐Otín, Gerard Piñol‐Ripoll, Mónica Povedano, Pol Andrés‐Benito   +19 more
wiley   +1 more source

Between two worlds

Free Neuropathology, 2020
Peter Lantos
doaj   +1 more source

Trends in neuropathology training in Sub-Saharan Africa - current curricula, resource gaps, and the potential of virtual microscopy and telemedicine. [PDF]

Free Neuropathol
Jagunmolu H, Oyetola E, Ajagbe K, Oyelude S, Jubreel M, Afolayan O, Abimbola D, Ismail A, Oyeniran K, Ibrahim M, Oguntola B.   +10 more
europepmc   +1 more source

Associations between TMEM106B C‐terminal fragment aggregation, age, and TDP‐43 or tau pathology

Brain Pathology, EarlyView.
TMEM106B C‐terminal fragment (CTF) aggregation represents an age‐associated, common, diffuse phenomenon emerging after midlife with a weak association with TDP‐43 or tau pathology. These findings suggest that TMEM106B fibrillization may define a distinct axis of protein aggregation in the aging human brain. Abstract Transmembrane protein 106B (TMEM106B)
Albert Acewicz, Sylwia Tarka, Michał Grzegorczyk, Radosław Rzepliński, Teresa Wierzba‐Bobrowicz, Tomasz Stępień   +5 more
wiley   +1 more source

Angiotensin II-Stimulating Antihypertensive Medications and Dementia-Related Neuropathology. [PDF]

JAMA Netw Open
Gray SL, Yu O, Gatto NM, Marcum ZA, Latimer CS, Postupna N, Su YR, Barthold D, van Dalen JW, Richard E, Keene CD, Shaw PA, McEvoy LK, Larson EB, Crane PK.   +14 more
europepmc   +1 more source

Visceral neuropathology

Gastroenterology, 1978
openaire   +2 more sources

A 50‐year‐old man with a 12‐year history of extensive pachymeningeal thickening

Brain Pathology, EarlyView.
Alyssa M. Lee, Siddhartha Gaddamanugu, Kathyrn L. Eschbacher, Aishwarya Ravindran   +3 more
wiley   +1 more source

Clinical and molecular features of primary gliosarcoma with digital spatial whole‐transcriptome analysis of glial and mesenchymal components

Brain Pathology, EarlyView.
We report the clinical and genetic features of an institutional cohort of primary adult gliosarcomas compared to glioblastoma. We performed spatial whole‐transcriptome analysis on glial and sarcomatous regions of four cases to compare gene expression profiles and validated differential protein expression for two markers in tissue sections.
Matthew D. Wood, Gabriel Zangirolani, Jinho Lee, Melanie H. Hakar, Tanaya Neff, Kevin Y. Zhang, Christopher L. Corless   +6 more
wiley   +1 more source

Editorial: The role of gene mutations in the neuropathology of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD)– Progress and challenges

Frontiers in Neurology, 2023
Claire Troakes, Francesca Luisa Conforti
doaj   +1 more source

Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespan. [PDF]

Acta Neuropathol
Pascual JR, Rivera I, Nguyen H, Ngo PT, Hoang A, Andrews EJ, Rouanet J, Wright ST, Sordo L, Kofler J, Ikonomovic MD, Lai F, Mapstone M, Christian BT, Handen BL, Lott IT, Doran E, Hom CL, Harp J, Schmitt F, Tudorascu DL, Ances BM, Phelan M, Liu L, Flores-Aguilar L, Head E, Alzheimer’s Biomarkers Consortium–Down Syndrome (ABC-DS) Investigators.   +26 more
europepmc   +1 more source